Eli Lilly is developing what could be the first oral GLP-1 agonist. Late-stage clinical trial data is coming this year. The stock has a steep valuation despite trading sideways since the summer ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical company’s weight-loss drug. Hours after Hims & Hers posted a blog ...

Aiming to create a "harmonic and sinuous" yet sturdy form for the bent bases, several woods were tested during the design process. "Every wood has its own characteristics, so we had to respect ...

As he adjusts the blinds in the study of his south London home, Elis James is in a good mood. "I feel fantastic," he says, as he tames the sunlight that had streamed in through the shutters ...

Bradley Devlin is politics editor for The Daily Signal. Send an email to Bradley. Rep. Eli Crane, R-Ariz., is a fighter. The week after 9/11, he dropped out of the University of Arizona to join ...

Bachelor Grant Ellis found his happily ever after with fiancée Juliana Pasquarosa — and he’s not here for the haters. “When Bach nation is everyone tryna get clout by taking shots and you ...

Eli Lilly (NYSE:LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass compounding its blockbuster GLP-1/GIP receptor agonist tirzepatide. Tirzepatide is ...

This is roughly $800 more than the list price Eli Lilly & Co. charges for its drug, and includes a Hims membership, unlimited consultations with a provider and treatment support, the spokesperson ...

WNBA star Caitlin Clark, tennis legend Serena Williams and football icon Eli Manning joined forces at the NFL's annual meetings at Palm Beach, Florida. Sure enough, it was quite the momentous ...

Senior tight end Eli Raridon is gearing up for his final year at Notre Dame. The former four star tight end first arrived on campus in 2022, but two major knee injuries early in his career ...

The boss of US pharmaceutical giant Eli Lilly has told the BBC there is no looking back from Donald Trump's decision to impose sweeping tariffs on imports from the rest of the world. In an ...